Questions
Questions
Single choice

In the pharmaceutical industry, branded drug manufacturers (e.g., Pfizer, Merck) and generic drug manufacturers operate in distinct strategic groups. Branded firms rely on patents and heavy R&D investment, while generics focus on low-cost production. How do mobility barriers protect the profitability of branded drug makers?

Options
A.Market size alone ensures profitability, regardless of strategic group dynamics.
B.Branded firms can easily imitate generic pricing strategies, eliminating profitability differences.
C.Patents and regulatory approvals act as mobility barriers, shielding branded firms from generic rivals entering their group.
D.Generic firms avoid entering the branded group due to high advertising costs, limiting competition.
View Explanation

View Explanation

Verified Answer
Please login to view
Step-by-Step Analysis
The question asks how mobility barriers protect the profitability of branded drug makers in the competition between branded firms and generic manufacturers. Option 1: 'Market size alone ensures profitability, regardless of strategic group dynamics.' While market size matters, profitability is not guaranteed solely by size. Mobility barriers like patents and regulatory protections limit entry by rivals within the same strategic space, so this st......Login to view full explanation

Log in for full answers

We've collected over 50,000 authentic exam questions and detailed explanations from around the globe. Log in now and get instant access to the answers!

Similar Questions

More Practical Tools for Students Powered by AI Study Helper

Join us and instantly unlock extensive past papers & exclusive solutions to get a head start on your studies!